{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:08:12Z","timestamp":1793826492806,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008665","name":"Osaka Medical Research Foundation for Intractable Diseases","doi-asserted-by":"publisher","award":["21K15699"],"award-info":[{"award-number":["21K15699"]}],"id":[{"id":"10.13039\/501100008665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008665","name":"Osaka Medical Research Foundation for Intractable Diseases","doi-asserted-by":"publisher","award":["24K12069"],"award-info":[{"award-number":["24K12069"]}],"id":[{"id":"10.13039\/501100008665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008665","name":"Osaka Medical Research Foundation for Intractable Diseases","doi-asserted-by":"publisher","award":["23K08333"],"award-info":[{"award-number":["23K08333"]}],"id":[{"id":"10.13039\/501100008665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008665","name":"Osaka Medical Research Foundation for Intractable Diseases","doi-asserted-by":"publisher","award":["23K08383"],"award-info":[{"award-number":["23K08383"]}],"id":[{"id":"10.13039\/501100008665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ibneur.2025.12.001","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T17:30:58Z","timestamp":1764869458000},"page":"1053-1062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Levodopa exerts neuroprotective effects by suppressing microglial proinflammatory activation in a rat hemi-Parkinson\u2019s disease model"],"prefix":"10.1016","volume":"19","author":[{"given":"Noriyuki","family":"Miyaue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2658-5487","authenticated-orcid":false,"given":"Mohammed E.","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4951-9359","authenticated-orcid":false,"given":"Ikuko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayane","family":"Takenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruto","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ibneur.2025.12.001_bib1","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/glia.23469","article-title":"Comparison of the detrimental features of microglia and infiltrated macrophages in traumatic brain injury: a study using a hypnotic bromovalerylurea","volume":"66","author":"Abe","year":"2018","journal-title":"Glia"},{"issue":"11","key":"10.1016\/j.ibneur.2025.12.001_bib2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/glia.23199","article-title":"Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus","volume":"65","author":"Aono","year":"2017","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.001_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12974-024-03091-x","article-title":"Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity","volume":"21","author":"Ayerra","year":"2024","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.001_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharm. Rev."},{"issue":"4","key":"10.1016\/j.ibneur.2025.12.001_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-2236(03)00038-9","article-title":"Presymptomatic compensation in Parkinson's disease is not dopamine-mediated","volume":"26","author":"Bezard","year":"2003","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.001_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12964-024-01478-0","article-title":"Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson's disease","volume":"22","author":"Chen","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"8","key":"10.1016\/j.ibneur.2025.12.001_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083907","article-title":"Dual Roles of Microglia in the Basal Ganglia in Parkinson's Disease","volume":"22","author":"Choudhury","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.001_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/glia.23698","article-title":"Phagocytic elimination of synapses by microglia during sleep","volume":"68","author":"Choudhury","year":"2020","journal-title":"Glia"},{"issue":"15","key":"10.1016\/j.ibneur.2025.12.001_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157824","article-title":"Microglia and the Aging Brain: Are Geriatric Microglia Linked to Poor Sleep Quality?","volume":"22","author":"Choudhury","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.001_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/brb3.11","article-title":"A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats","volume":"1","author":"Choudhury","year":"2011","journal-title":"Brain Behav."},{"issue":"11","key":"10.1016\/j.ibneur.2025.12.001_bib11","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy","volume":"29","author":"Chung","year":"2009","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.ibneur.2025.12.001_bib12","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of parkinson\u2019s disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.001_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mcn.2005.01.003","article-title":"Dopamine and noradrenaline control distinct functions in rodent microglial cells","volume":"29","author":"Farber","year":"2005","journal-title":"Mol. Cell Neurosci."},{"issue":"2","key":"10.1016\/j.ibneur.2025.12.001_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-006-0096-2","article-title":"Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra","volume":"112","author":"Galvin","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ibneur.2025.12.001_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173945","article-title":"Pramipexole decreases allodynia and hyperalgesia via NF-kappaB in astrocytes in rats with Parkinson's disease","volume":"247","author":"Godinez-Chaparro","year":"2025","journal-title":"Pharm. Biochem Behav."},{"issue":"8","key":"10.1016\/j.ibneur.2025.12.001_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","article-title":"ER stress and the unfolded protein response in neurodegeneration","volume":"13","author":"Hetz","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ibneur.2025.12.001_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuint.2016.06.013","article-title":"The hypnotic bromovalerylurea ameliorates 6-hydroxydopamine-induced dopaminergic neuron loss while suppressing expression of interferon regulatory factors by microglia","volume":"99","author":"Higaki","year":"2016","journal-title":"Neurochem. Int"},{"issue":"4","key":"10.1016\/j.ibneur.2025.12.001_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"15","key":"10.1016\/j.ibneur.2025.12.001_bib19","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","article-title":"Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial","volume":"284","author":"Holloway","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ibneur.2025.12.001_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuint.2015.07.010","article-title":"Anti-inflammatory effects of noradrenaline on LPS-treated microglial cells: Suppression of NFkappaB nuclear translocation and subsequent STAT1 phosphorylation","volume":"90","author":"Ishii","year":"2015","journal-title":"Neurochem. Int"},{"issue":"3","key":"10.1016\/j.ibneur.2025.12.001_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbadis.2017.12.022","article-title":"Sustained anti-inflammatory effects of TGF-beta1 on microglia\/macrophages","volume":"1864","author":"Islam","year":"2018","journal-title":"Biochim Biophys. Acta"},{"issue":"11","key":"10.1016\/j.ibneur.2025.12.001_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41419-024-07252-x","article-title":"Neuroprotective effect of L-DOPA-induced interleukin-13 on striatonigral degeneration in cerebral ischemia","volume":"15","author":"Jeon","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ibneur.2025.12.001_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of general and discriminating markers of differential microglia phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.ibneur.2025.12.001_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2019.03.012","article-title":"Toll-like receptors in the pathogenesis of neuroinflammation","volume":"332","author":"Kumar","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ibneur.2025.12.001_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbi.2020.07.044","article-title":"Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson's disease","volume":"90","author":"Lecours","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ibneur.2025.12.001_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146780","article-title":"Small dose of L-dopa\/Benserazide hydrochloride improved sepsis-induced neuroinflammation and long-term cognitive dysfunction in sepsis mice","volume":"1737","author":"Li","year":"2020","journal-title":"Brain Res"},{"key":"10.1016\/j.ibneur.2025.12.001_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuint.2018.11.005","article-title":"Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson's disease model","volume":"122","author":"Miyanishi","year":"2019","journal-title":"Neurochem. Int"},{"issue":"6","key":"10.1016\/j.ibneur.2025.12.001_bib28","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0028-3908(02)00211-3","article-title":"Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors","volume":"43","author":"Mori","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ibneur.2025.12.001_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105479","article-title":"Anti-inflammatory effects of dopamine on microglia and a D1 receptor agonist ameliorates neuroinflammation of the brain in a rat delirium model","volume":"163","author":"Nishikawa","year":"2023","journal-title":"Neurochem. Int"},{"issue":"2","key":"10.1016\/j.ibneur.2025.12.001_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9020139","article-title":"The Role of the renal dopaminergic system and oxidative stress in the pathogenesis of hypertension","volume":"9","author":"Qaddumi","year":"2021","journal-title":"Biomedicines"},{"issue":"JUL","key":"10.1016\/j.ibneur.2025.12.001_bib31","article-title":"The role of microglia in retinal neurodegeneration: Alzheimer's disease, Parkinson, and glaucoma","volume":"9","author":"Ramirez","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2025.12.001_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"JUN","key":"10.1016\/j.ibneur.2025.12.001_bib33","article-title":"Aging microglia-phenotypes, functions and implications for age-related neurodegenerative diseases","volume":"9","author":"Spittau","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.ibneur.2025.12.001_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jb\/mvad030","article-title":"The anti-inflammatory and anti-oxidative effect of a classical hypnotic bromovalerylurea mediated by the activation of NRF2","volume":"174","author":"Takeda","year":"2023","journal-title":"J. Biochem"},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.001_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jphs.2020.11.007","article-title":"Microglial metabolic disturbances and neuroinflammation in cerebral infarction","volume":"145","author":"Takeda","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.001_bib36","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1038\/s41467-022-31773-8","article-title":"Controlled activation of cortical astrocytes modulates neuropathic pain-like behaviour","volume":"13","author":"Takeda","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ibneur.2025.12.001_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y","article-title":"Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species","volume":"28","author":"Tanaka","year":"1999","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.ibneur.2025.12.001_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109587","article-title":"A dopamine D1-like receptor-specific agonist improves the survival of septic mice","volume":"27","author":"Tanaka","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.ibneur.2025.12.001_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(93)90834-5","article-title":"The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys","volume":"235","author":"Vermeulen","year":"1993","journal-title":"Eur. J. Pharm."},{"issue":"4","key":"10.1016\/j.ibneur.2025.12.001_bib40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJMoa1809983","article-title":"Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease","volume":"380","author":"Verschuur","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"7","key":"10.1016\/j.ibneur.2025.12.001_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson's disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ibneur.2025.12.001_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109847","article-title":"Dopamine suppresses osteoclast differentiation via cAMP\/PKA\/CREB pathway","volume":"78","author":"Wang","year":"2021","journal-title":"Cell Signal"},{"key":"10.1016\/j.ibneur.2025.12.001_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"issue":"12","key":"10.1016\/j.ibneur.2025.12.001_bib44","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","article-title":"The promise of minocycline in neurology","volume":"3","author":"Yong","year":"2004","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.ibneur.2025.12.001_bib45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0028-3908(01)00174-5","article-title":"Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents","volume":"42","author":"Zhang","year":"2002","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.ibneur.2025.12.001_bib46","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archneur.1984.04050190062015","article-title":"Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical Parkinsonism","volume":"41","author":"Zigmond","year":"1984","journal-title":"Arch. Neurol."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125001939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125001939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:22:01Z","timestamp":1778930521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242125001939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"alternative-id":["S2667242125001939"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.12.001","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levodopa exerts neuroprotective effects by suppressing microglial proinflammatory activation in a rat hemi-Parkinson\u2019s disease model","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}